Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS).

Landgren CO, Chari A, Cohen YC, Spencer A, Voorhees P, Estell JA, Sandhu I, Jenner MW, Williams C, Cavo M, van de Donk NWCJ, Beksac M, Moreau P, Goldschmidt H, Kuppens S, Bandekar R, Clemens PL, Neff T, Heuck C, Qi M, Hofmeister CC.

Leukemia. 2020 Feb 5. doi: 10.1038/s41375-020-0718-z. [Epub ahead of print]

PMID:
32024950
2.

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.

Richeldi L, Fernández Pérez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G.

Lancet Respir Med. 2020 Jan;8(1):25-33. doi: 10.1016/S2213-2600(19)30262-0. Epub 2019 Sep 28.

PMID:
31575509
3.

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.

Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C, Liang X, Jiang G, Liu Z, Li X, Zuo L, Luo L, Wang J, Zhao MH, Liu Z, Cai GY, Hao L, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP.

N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24.

PMID:
31340116
4.

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

Chen N, Hao C, Peng X, Lin H, Yin A, Hao L, Tao Y, Liang X, Liu Z, Xing C, Chen J, Luo L, Zuo L, Liao Y, Liu BC, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP.

N Engl J Med. 2019 Sep 12;381(11):1001-1010. doi: 10.1056/NEJMoa1813599. Epub 2019 Jul 24.

PMID:
31340089
5.

Hemorrhagic shock induces renal complement activation.

Ehrnthaller C, Schultze A, Wakileh G, Neff T, Hafner S, Radermacher P, Huber-Lang M.

Eur J Trauma Emerg Surg. 2019 Jul 15. doi: 10.1007/s00068-019-01187-1. [Epub ahead of print]

PMID:
31309238
6.

The role of polycomb repressive complex 2 in early T-cell precursor acute lymphoblastic leukemia.

Bernt KM, Neff T.

Mol Cell Oncol. 2018 May 16;5(5):e1166309. doi: 10.1080/23723556.2016.1166309. eCollection 2018.

7.

Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.

Hart MR, Anderson DJ, Porter CC, Neff T, Levin M, Horwitz MS.

PLoS Genet. 2018 Sep 14;14(9):e1007642. doi: 10.1371/journal.pgen.1007642. eCollection 2018 Sep.

8.

AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.

Pei S, Minhajuddin M, Adane B, Khan N, Stevens BM, Mack SC, Lai S, Rich JN, Inguva A, Shannon KM, Kim H, Tan AC, Myers JR, Ashton JM, Neff T, Pollyea DA, Smith CA, Jordan CT.

Cell Stem Cell. 2018 Jul 5;23(1):86-100.e6. doi: 10.1016/j.stem.2018.05.021. Epub 2018 Jun 14.

9.

Mortality rates and risk factors for emergent open repair of abdominal aortic aneurysms in the endovascular era.

Pecoraro F, Gloekler S, Mader CE, Roos M, Chaykovska L, Veith FJ, Cayne NS, Mangialardi N, Neff T, Lachat M.

Updates Surg. 2018 Mar;70(1):129-136. doi: 10.1007/s13304-017-0488-y. Epub 2017 Sep 14.

PMID:
28913787
10.

Mid-term Results of Chimney and Periscope Grafts in Supra-aortic Branches in High Risk Patients.

Pecoraro F, Lachat M, Cayne NS, Pakeliani D, Rancic Z, Puippe G, Criado FJ, Pfammatter T, Veith FJ, Krüger B, Neff TA.

Eur J Vasc Endovasc Surg. 2017 Sep;54(3):295-302. doi: 10.1016/j.ejvs.2017.06.014. Epub 2017 Jul 25.

11.

MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.

Chen Y, Anastassiadis K, Kranz A, Stewart AF, Arndt K, Waskow C, Yokoyama A, Jones K, Neff T, Lee Y, Ernst P.

Cancer Cell. 2017 Jun 12;31(6):755-770.e6. doi: 10.1016/j.ccell.2017.05.002.

12.

Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions.

Gay ND, Wang Y, Beadling C, Warrick A, Neff T, Corless CL, Tolba K.

J Thorac Oncol. 2017 Aug;12(8):e107-e110. doi: 10.1016/j.jtho.2017.04.025. Epub 2017 May 10. No abstract available.

13.

Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.

Chen N, Qian J, Chen J, Yu X, Mei C, Hao C, Jiang G, Lin H, Zhang X, Zuo L, He Q, Fu P, Li X, Ni D, Hemmerich S, Liu C, Szczech L, Besarab A, Neff TB, Peony Yu KH, Valone FH.

Nephrol Dial Transplant. 2017 Aug 1;32(8):1373-1386. doi: 10.1093/ndt/gfx011.

14.
15.

Mid-term results of zone 0 thoracic endovascular aneurysm repair after ascending aorta wrapping and supra-aortic debranching in high-risk patients.

Pecoraro F, Lachat M, Hofmann M, Cayne NS, Chaykovska L, Rancic Z, Puippe G, Pfammatter T, Mangialardi N, Veith FJ, Bettex D, Maisano F, Neff TA.

Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):882-889. doi: 10.1093/icvts/ivx016.

PMID:
28329189
16.

Towards MRI-Based Autonomous Robotic US Acquisitions: A First Feasibility Study.

Hennersperger C, Fuerst B, Virga S, Zettinig O, Frisch B, Neff T, Navab N.

IEEE Trans Med Imaging. 2017 Feb;36(2):538-548. doi: 10.1109/TMI.2016.2620723. Epub 2016 Oct 24.

PMID:
27831861
17.

Sox2 and Lef-1 interact with Pitx2 to regulate incisor development and stem cell renewal.

Sun Z, Yu W, Sanz Navarro M, Sweat M, Eliason S, Sharp T, Liu H, Seidel K, Zhang L, Moreno M, Lynch T, Holton NE, Rogers L, Neff T, Goodheart MJ, Michon F, Klein OD, Chai Y, Dupuy A, Engelhardt JF, Chen Z, Amendt BA.

Development. 2016 Nov 15;143(22):4115-4126. Epub 2016 Sep 22.

18.

Analgesic efficacy of equimolar 50% nitrous oxide/oxygen gas premix (Kalinox®) as compared with a 5% eutectic mixture of lidocaine/prilocaine (EMLA®) in chronic leg ulcer debridement.

Traber J, Held U, Signer M, Huebner T, Arndt S, Neff TA.

Int Wound J. 2017 Aug;14(4):606-615. doi: 10.1111/iwj.12652. Epub 2016 Aug 8.

PMID:
27500801
19.

Wnt Signaling Regulates Airway Epithelial Stem Cells in Adult Murine Submucosal Glands.

Lynch TJ, Anderson PJ, Xie W, Crooke AK, Liu X, Tyler SR, Luo M, Kusner DM, Zhang Y, Neff T, Burnette DC, Walters KS, Goodheart MJ, Parekh KR, Engelhardt JF.

Stem Cells. 2016 Nov;34(11):2758-2771. doi: 10.1002/stem.2443. Epub 2016 Jul 11.

20.

The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and Opportunities.

Bernt KM, Hunger SP, Neff T.

Front Pediatr. 2016 May 18;4:49. doi: 10.3389/fped.2016.00049. eCollection 2016. Review.

21.

Which Anesthesia Regimen Is Best to Reduce Morbidity and Mortality in Lung Surgery?: A Multicenter Randomized Controlled Trial.

Beck-Schimmer B, Bonvini JM, Braun J, Seeberger M, Neff TA, Risch TJ, Stüber F, Vogt A, Weder W, Schneiter D, Filipovic M, Puhan M.

Anesthesiology. 2016 Aug;125(2):313-21. doi: 10.1097/ALN.0000000000001164.

22.

Conditional deletion of Sox17 reveals complex effects on uterine adenogenesis and function.

Guimarães-Young A, Neff T, Dupuy AJ, Goodheart MJ.

Dev Biol. 2016 Jun 15;414(2):219-27. doi: 10.1016/j.ydbio.2016.04.010. Epub 2016 Apr 19.

23.

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

Provenzano R, Besarab A, Sun CH, Diamond SA, Durham JH, Cangiano JL, Aiello JR, Novak JE, Lee T, Leong R, Roberts BK, Saikali KG, Hemmerich S, Szczech LA, Yu KH, Neff TB.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):982-91. doi: 10.2215/CJN.06890615. Epub 2016 Apr 19.

24.

Dynamical phase diagram of Gaussian wave packets in optical lattices.

Hennig H, Neff T, Fleischmann R.

Phys Rev E. 2016 Mar;93(3):032219. doi: 10.1103/PhysRevE.93.032219. Epub 2016 Mar 22.

PMID:
27078356
25.

FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.

Raghu G, Scholand MB, de Andrade J, Lancaster L, Mageto Y, Goldin J, Brown KK, Flaherty KR, Wencel M, Wanger J, Neff T, Valone F, Stauffer J, Porter S.

Eur Respir J. 2016 May;47(5):1481-91. doi: 10.1183/13993003.01030-2015. Epub 2016 Mar 10.

26.

MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.

Riedel SS, Haladyna JN, Bezzant M, Stevens B, Pollyea DA, Sinha AU, Armstrong SA, Wei Q, Pollock RM, Daigle SR, Jordan CT, Ernst P, Neff T, Bernt KM.

J Clin Invest. 2016 Apr 1;126(4):1438-50. doi: 10.1172/JCI80825. Epub 2016 Feb 29.

27.

Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.

Danis E, Yamauchi T, Echanique K, Zhang X, Haladyna JN, Riedel SS, Zhu N, Xie H, Orkin SH, Armstrong SA, Bernt KM, Neff T.

Cell Rep. 2016 Mar 1;14(8):1953-65. doi: 10.1016/j.celrep.2016.01.064. Epub 2016 Feb 18.

28.

Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.

Provenzano R, Besarab A, Wright S, Dua S, Zeig S, Nguyen P, Poole L, Saikali KG, Saha G, Hemmerich S, Szczech L, Yu KH, Neff TB.

Am J Kidney Dis. 2016 Jun;67(6):912-24. doi: 10.1053/j.ajkd.2015.12.020. Epub 2016 Feb 2.

29.

A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.

Beadling C, Wald AI, Warrick A, Neff TL, Zhong S, Nikiforov YE, Corless CL, Nikiforova MN.

J Mol Diagn. 2016 Mar;18(2):165-75. doi: 10.1016/j.jmoldx.2015.10.002. Epub 2015 Dec 30.

30.

Paving the Road for Modern Particle Therapy - What Can We Learn from the Experience Gained with Fast Neutron Therapy in Munich?

Specht HM, Neff T, Reuschel W, Wagner FM, Kampfer S, Wilkens JJ, Petry W, Combs SE.

Front Oncol. 2015 Nov 27;5:262. doi: 10.3389/fonc.2015.00262. eCollection 2015.

31.

Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.

Besarab A, Chernyavskaya E, Motylev I, Shutov E, Kumbar LM, Gurevich K, Chan DT, Leong R, Poole L, Zhong M, Saikali KG, Franco M, Hemmerich S, Yu KH, Neff TB.

J Am Soc Nephrol. 2016 Apr;27(4):1225-33. doi: 10.1681/ASN.2015030241. Epub 2015 Oct 22.

32.

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.

Besarab A, Provenzano R, Hertel J, Zabaneh R, Klaus SJ, Lee T, Leong R, Hemmerich S, Yu KH, Neff TB.

Nephrol Dial Transplant. 2015 Oct;30(10):1665-73. doi: 10.1093/ndt/gfv302. Epub 2015 Aug 3.

33.

Histone profiles in cancer.

Riedel SS, Neff T, Bernt KM.

Pharmacol Ther. 2015 Oct;154:87-109. doi: 10.1016/j.pharmthera.2015.07.004. Epub 2015 Jul 22. Review.

PMID:
26210403
34.

Late Post-Conditioning with Sevoflurane after Cardiac Surgery--Are Surrogate Markers Associated with Clinical Outcome?

Bonvini JM, Beck-Schimmer B, Kuhn SJ, Graber SM, Neff TA, Schläpfer M.

PLoS One. 2015 Jul 21;10(7):e0132165. doi: 10.1371/journal.pone.0132165. eCollection 2015.

35.

Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model.

Danis E, Yamauchi T, Echanique K, Haladyna J, Kalkur R, Riedel S, Zhu N, Xie H, Bernt KM, Orkin SH, Armstrong SA, Neff T.

Exp Hematol. 2015 Nov;43(11):930-935.e6. doi: 10.1016/j.exphem.2015.06.005. Epub 2015 Jun 26.

36.

Epigenetic modifiers in normal and malignant hematopoiesis.

Haladyna JN, Yamauchi T, Neff T, Bernt KM.

Epigenomics. 2015;7(2):301-20. doi: 10.2217/epi.14.88. Review.

PMID:
25942537
37.

CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice.

Xie W, Fisher JT, Lynch TJ, Luo M, Evans TI, Neff TL, Zhou W, Zhang Y, Ou Y, Bunnett NW, Russo AF, Goodheart MJ, Parekh KR, Liu X, Engelhardt JF.

J Clin Invest. 2015 May;125(5):2179. doi: 10.1172/JCI82138. Epub 2015 May 1. No abstract available.

38.

Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets.

Ang D, Ballard M, Beadling C, Warrick A, Schilling A, O'Gara R, Pukay M, Neff TL, West RB, Corless CL, Troxell ML.

Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):97-103. doi: 10.1097/PDM.0b013e3182a40fd1.

PMID:
25679062
39.

Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data.

Grasso C, Butler T, Rhodes K, Quist M, Neff TL, Moore S, Tomlins SA, Reinig E, Beadling C, Andersen M, Corless CL.

J Mol Diagn. 2015 Jan;17(1):53-63. doi: 10.1016/j.jmoldx.2014.09.008. Epub 2014 Nov 7.

41.

OpenIGTLink interface for state control and visualisation of a robot for image-guided therapy systems.

Tauscher S, Tokuda J, Schreiber G, Neff T, Hata N, Ortmaier T.

Int J Comput Assist Radiol Surg. 2015 Mar;10(3):285-92. doi: 10.1007/s11548-014-1081-1. Epub 2014 Jun 13.

42.

Mutation profiling in gallbladder cancer in Indian population.

Kumari N, Corless CL, Warrick A, Beadling C, Nelson D, Neff T, Krishnani N, Kapoor VK.

Indian J Pathol Microbiol. 2014 Jan-Mar;57(1):9-12. doi: 10.4103/0377-4929.130849.

43.

Early fluid resuscitation with hydroxyethyl starch 130/0.4 (6%) in severe burn injury: a randomized, controlled, double-blind clinical trial.

Béchir M, Puhan MA, Fasshauer M, Schuepbach RA, Stocker R, Neff TA.

Crit Care. 2013 Dec 23;17(6):R299. doi: 10.1186/cc13168.

44.

Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer.

Barnett CM, Heinrich MC, Lim J, Nelson D, Beadling C, Warrick A, Neff T, Higano CS, Garzotto M, Qian D, Corless CL, Thomas GV, Beer TM.

Clin Cancer Res. 2014 Mar 1;20(5):1306-12. doi: 10.1158/1078-0432.CCR-13-1775. Epub 2013 Dec 18.

45.

Mapping cellular hierarchy by single-cell analysis of the cell surface repertoire.

Guo G, Luc S, Marco E, Lin TW, Peng C, Kerenyi MA, Beyaz S, Kim W, Xu J, Das PP, Neff T, Zou K, Yuan GC, Orkin SH.

Cell Stem Cell. 2013 Oct 3;13(4):492-505. doi: 10.1016/j.stem.2013.07.017. Epub 2013 Sep 12.

46.

Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer.

Kim W, Bird GH, Neff T, Guo G, Kerenyi MA, Walensky LD, Orkin SH.

Nat Chem Biol. 2013 Oct;9(10):643-50. doi: 10.1038/nchembio.1331. Epub 2013 Aug 25.

47.

Recent progress toward epigenetic therapies: the example of mixed lineage leukemia.

Neff T, Armstrong SA.

Blood. 2013 Jun 13;121(24):4847-53. doi: 10.1182/blood-2013-02-474833. Epub 2013 May 6. Review.

48.

Changes and regulation of the C5a receptor on neutrophils during septic shock in humans.

Unnewehr H, Rittirsch D, Sarma JV, Zetoune F, Flierl MA, Perl M, Denk S, Weiss M, Schneider ME, Monk PN, Neff T, Mihlan M, Barth H, Gebhard F, Ward PA, Huber-Lang M.

J Immunol. 2013 Apr 15;190(8):4215-25. doi: 10.4049/jimmunol.1200534. Epub 2013 Mar 11.

49.

The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study.

Wenger U, Neff TA, Oberkofler CE, Zimmermann M, Stehberger PA, Scherrer M, Schuepbach RA, Cottini SR, Steiger P, Béchir M.

BMC Nephrol. 2013 Feb 14;14:37. doi: 10.1186/1471-2369-14-37.

50.

Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping.

Beadling C, Neff TL, Heinrich MC, Rhodes K, Thornton M, Leamon J, Andersen M, Corless CL.

J Mol Diagn. 2013 Mar;15(2):171-6. doi: 10.1016/j.jmoldx.2012.09.003. Epub 2012 Dec 27.

Supplemental Content

Support Center